K25.ai Announces $10 Million Pre-A Financing at $100 Million Post-Money Valuation

According to K25.ai, Nasdaq-listed NewGenIVF Group made an initial $2 million investment at a $100 million valuation, with potential expansion to $10 million and Asia-Pacific partnership rights tied to regional growth plans.

Summary

K25.ai said it secured a $10 million Pre-A strategic financing at a $100 million post-money valuation, with Nasdaq-listed NewGenIVF Group providing an initial $2 million investment. The company now says the investment could increase to $10 million and gives NewGenIVF exclusive institutional partnership rights in Asia-Pacific. K25.ai and NewGenIVF plan to expand across Singapore, Thailand, Japan, Australia, and New Zealand. K25.ai previously said it was evaluating strategic transactions, including a reverse takeover, while noting that no listing plan had been confirmed.

Terms & Concepts
  • Pre-A financing: An early-stage fundraising round that typically comes before a formal Series A and is used to support product development and growth.
  • Post-money valuation: A company’s estimated value immediately after new investment capital is added.
  • Reverse takeover: A transaction in which a private company gains a public market listing by combining with or acquiring a publicly listed company.